(EnergyIndustry.Net, October 12, 2017 ) According to Publisher, the Global Periodontal Therapeutics Market is valued at $259.34 million in 2016 and is expected to reach $511.76 million by 2023 growing at a CAGR of 10.2% from 2016 to 2023. Owing to increasing pool of diabetic patients will raise the Periodontal Therapeutics market growth. In addition, rising prevalence of periodontal disorders and the surging research activities for technological advancements in therapeutics are some factors positively impacting the growth. On the other hand, lack of favourable reimbursement policies in various countries across the world may limit the growth of this market.
By product, systemic antibiotics segment have the largest market share and is expected to remain the same for next few years due to high market penetration by product affordability. Followed by local antibiotics segment expected to grow faster due less chances of formation of resistant bacteria following fewer side effects. North American region has the largest market share in periodontal therapeutics market by increasing healthcare expenditure leading to increased demand for better oral healthcare therapeutics. Asia Pacific region is expected to grow at a higher CAGR during the forecast period owing to its population growth.
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -U.K -France -Italy -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -South Korea -Rest of Asia Pacific -South America -Argentina -Brazil -Chile -Rest of South America -Middle East & Africa -Saudi Arabia -UAE -Qatar -South Africa